BiomX Inc.
PHGE
$0.601
-$0.01-1.64%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.03M | 3.25M | 3.57M | 1.94M | 3.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.51M | 10.53M | 10.47M | 6.04M | 5.27M |
| Operating Income | -8.51M | -10.53M | -10.47M | -6.04M | -5.27M |
| Income Before Tax | -14.51M | 9.64M | 4.48M | -17.32M | -5.49M |
| Income Tax Expenses | 3.00K | -- | 5.00K | 5.00K | 1.00K |
| Earnings from Continuing Operations | -14.51M | 9.64M | 4.47M | -17.33M | -5.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.51M | 9.64M | 4.47M | -17.33M | -5.49M |
| EBIT | -8.51M | -10.53M | -10.47M | -6.04M | -5.27M |
| EBITDA | -7.59M | -10.21M | -10.14M | -5.82M | -5.06M |
| EPS Basic | -0.80 | 0.31 | 0.76 | -2.22 | -0.90 |
| Normalized Basic EPS | -0.22 | 0.40 | 0.15 | -1.66 | -0.57 |
| EPS Diluted | -0.89 | 0.31 | -1.83 | -2.22 | -0.91 |
| Normalized Diluted EPS | -0.22 | 0.40 | 0.07 | -1.66 | -0.57 |
| Average Basic Shares Outstanding | 18.24M | 16.37M | 7.24M | 6.23M | 6.07M |
| Average Diluted Shares Outstanding | 18.24M | 16.39M | 15.04M | 6.23M | 6.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |